{{Rsnum
|rsid=886441
|Gene=VDR
|Chromosome=12
|position=47869181
|Orientation=minus
|GMAF=0.2176
|Gene_s=VDR
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 5.3 | 24.8 | 69.9
| HCB | 0.7 | 8.8 | 90.4
| JPT | 1.8 | 5.3 | 92.9
| YRI | 17.0 | 46.3 | 36.7
| ASW | 14.0 | 56.1 | 29.8
| CHB | 0.7 | 8.8 | 90.4
| CHD | 0.9 | 9.2 | 89.9
| GIH | 3.0 | 27.7 | 69.3
| LWK | 19.1 | 45.5 | 35.5
| MEX | 8.6 | 41.4 | 50.0
| MKK | 12.2 | 46.2 | 41.7
| TSI | 5.9 | 30.4 | 63.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=22544453
|Title=Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma
|OA=1
}}

{{PMID|18593774|OA=1
}} Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans.

{{PMID|19682379|OA=1
}} TagSNP transferability and relative loss of variability prediction from HapMap to an admixed population.

{{PMID|19956101|OA=1
}} Overview of the Rapid Response data.

{{PMID|20049159|OA=1
}} Vitamin d pathway genes, diet, and risk of renal cell carcinoma.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}